Tag: IMUC

Blue Horseshoe Stocks: MZEI, SPY Recaps & More

Medizone International, Inc. MZEI

Continuing our recent good fortune with selecting stocks ripe for a rebound off of their 52-week lows, we listed MZEI as a point of interest in yesterday’s premarket report.

We want to quote what we said verbatim, as the stock’s performance so closely coincided with our expectations. We stated: “MZEI fell off a cliff yesterday…We’re going to slate this stock as a potential recovery play- support prior to that epic beating was in the .07-08 range, so we’ll be on the lookout for a rebound back to that region of the chart.”

As the session commenced, MZEI gapped up just past that .07-mark to .07225, and proceeded to run promptly to a daily high of .09, a 25% intraday move, and held a good portion of those gains into an eight-cent close. We’ll keep this one on our radars to watch for the possibility of a sustained rebound.

ETF Options Recap

Both of our options-trading ideas for ETFs worked out nicely yesterday:

Direxion Daily Gold Miners Index Bull 3X Shares (NUGT) – Our idea of tracking the NUGT Sept. 4th $5 Calls yesterday provided a significant chance for traders to make a double-bagger, as they rose from .27 to a high of .55, marking a total possible profit of 104%

*Side Note* We spotted abnormal volume in the NUGT 09/18 $5-7 Calls during yesterday’s session, so we’ll tag those for observation in coming weeks. NUGT is dipping back in the premarket today, which could provide us with a good buying opportunity.

___

SPDR S&P 500 ETF Trust (SPY) – We flagged SPY Weekly $206 Calls in our extended watchlist yesterday, and were instantaneously rewarded. Those contracts ran hard, jumping from a low of 1.08 all the way up to 3.24. That was good for a nice, round, 200% jump on the day, so congrats to any of our readers who took advantage of the heads up!

Eleven Biotherapeutics, Inc. EBIO

We also want to observe activity in EBIO as we head into week’s end. On Wednesday, they provided an update on one of their clinical trials, and this morning they’ve got an earnings drop (Links Below), leading to another premarket gap-up. We’ve pointed out the key aspects on the following chart snapshot, including the fact that an normous gap exists, the fillinf of which could mean significant added gains.

Extended Watchlist:
PLNR, OHGI, IMUC, CGRA(Marijuana News)

Blue Horseshoe Stocks: IMSC Update & More

Implant Sciences Corp. IMSC

We caught IMSC earlier this week on Tuesday, as it popped up on a routine news scan that morning; the company had announced a potentially lucrative contract with the TSA and the stock was gapping up pretty big.

It took a couple of sessions for the stock to come down and find support, and yesterday following an update on the TSA contract in which we learned that the initial order for over 1100 explosive detectors to be deployed in airports across the country was received, the stock began to run. >> Read PR

From an early low of 1.26 IMSC made a nice 22% intraday move, topping out at 1.54. We want to continue to pay attention to this play as the week comes to a close, in the wake of this morning’s Q1 2015 earnings release, which contains some favorable figures:


Off of Today’s News Scan

We’ll group our Extended Watchlist items together with links to the important PR’s each of the companies has out this morning.

Armco Metals Holdings, Inc. AMCO released earnings which beat expectations: ARMCO METALS HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report (Fri 8:32AM EST)

Geron Corp. GERN licensed its cancer treatment to a unit of Johnson & Johnson for up to $935 million: Geron could get $935M in blood disorder drug deal (Thu, Nov 13)

SkyPeople Fruit Juice, Inc. SPU announced vastly increased Q3 revs:SkyPeople Q3 Revenue Up 79% to $34.8 Million, Net Income Increases 45% to $4.7 Million (Fri 6:00AM EST)


Blonder Tongue Laboratories, Inc. BDR also released earnings today: BLONDER TONGUE LABORATORIES INC Files SEC form 10-Q, Quarterly Report (Fri 8:31AM EST)

Immunocellular Therapeutics, Inc. IMUC announced continued favorable results from trials of their dendritic cell-based immunotherapeutic vaccine: ImmunoCellular Therapeutics Presents Updated ICT-107 Phase II Data at the Society for Neuro-Oncology Annual Meeting 2014 (Fri 6:00AM EST)

Blue Horseshoe Stocks: SINO & PBR Updates

Sino-Global Shipping America Ltd. SINO

In yesterday’s newsletter, we mentioned that SINO was gapping up sharply in premarket trading, and as a result we would be on the lookout for a classic dip-and-rip pattern. That’s precisely what we got as SINO would settle into a low of 3.31 very early on, before springing back to run to a daily high of 4.69, which incidentally happened to be a new annual high as well.

In total the move was enough to secure up to 41% in intraday profits on incredible volume, to the tune of more than 58x the 3-month average.

This definitely signals a strong week for us; it marks the second consecutive session that a stock appearing in our pre-market report went on to set a new one-year high!

Petroleo Brasiliero S.A. (Petrobras) PBR- Options

The PBR Calls that we tagged in yesterday’s pre-market report fared extremely well as PBR once again surged past the $17-mark, and even cracked $18 briefly in the afternoon. The bullish run resulted in the $16.50 Calls trading up from .92 to 1.35, for a 47% intraday run, and the $17 Calls making an even better move. They started from a low .56 and spiked 105% to 1.15.

At this point our winning calls involving the PBR options chain, spanning back from early this spring, are too many to count. It has indeed been a wellspring that we’ve returned to time and again, and have almost always met with positive results.

Moving forward, we’ll be looking to roll our strike price up a bit to the $17 & $17.50 Calls, and in the event that PBR re-breaches and holds the $18-level, possibly even consider moving it up further to the $18’s and $18.50’s.

Extended Watchlist:
AUXL, IFON, AKS, CTIC, IMUC, PERI, OTIV